Oncology Precision Medicine Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

Oncology Precision Medicine Market is segmented By Type of Cancer (Bladder Cancer, Blood / Hematologic Cancer, Breast Cancer, Cervical Cancer, Gastrointestinal Cancer, Head and Neck Squamous Cell Cancer, Lung Cancer, Skin Cancer, Others), By Route of Administration (Oral, Intravenous, Others), By Type of Molecule (Small Molecules, Biologics), By Drug Class (Kinase Inhibitors, Enzyme Inhibitors, Immune Checkpoint Inhibitors, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Oncology Precision Medicine Market Leaders

  • AstraZeneca
  • Novartis
  • Pfeifen
  • Bristol-Myers Squibb
  • Rochen
*Disclaimer: Major players are listed in no particular order.

Oncology Precision Medicine Market - Company List

  • AstraZeneca
  • Novartis
  • Pfeifen
  • Bristol-Myers Squibb
  • Rochen
  • Amgen
  • BioNTech
  • Gilead Sciences
  • Merck & Co.
  • Illumina
  • Stiftungsmedizin
  • Gesundheitsschutz
  • Caris Life Sciences
  • Exakte
  • Myriad Genetics
  • Thermo Fisher Scientific
  • Invita
  • Genomische Gesundheit
  • Syapse
  • Tempus